EMERSON PERIN to Adult
This is a "connection" page, showing publications EMERSON PERIN has written about Adult.
Connection Strength
0.130
-
Adult stem cell therapy in perspective. Circulation. 2003 Feb 25; 107(7):935-8.
Score: 0.012
-
Comparison of left ventricular electromechanical mapping and left ventricular angiography: defining practical standards for analysis of NOGA maps. Tex Heart Inst J. 2003; 30(1):19-26.
Score: 0.012
-
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use. Cardiovasc Res. 2022 08 24; 118(11):2428-2436.
Score: 0.012
-
Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation. 2002 Aug 20; 106(8):957-61.
Score: 0.012
-
"Wireless" laser recanalization of chronic total coronary occlusions. J Invasive Cardiol. 2001 May; 13(5):401-5.
Score: 0.011
-
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial. Am Heart J. 2018 07; 201:54-62.
Score: 0.009
-
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis. Circ Res. 2018 02 02; 122(3):479-488.
Score: 0.009
-
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials. Basic Res Cardiol. 2017 01; 112(1):3.
Score: 0.008
-
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial. Am Heart J. 2016 09; 179:142-50.
Score: 0.008
-
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. Circ Res. 2015 Jan 02; 116(1):99-107.
Score: 0.007
-
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011 Nov 16; 306(19):2110-9.
Score: 0.006
-
Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction. J Nucl Cardiol. 2011 Oct; 18(5):912-9.
Score: 0.005
-
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Am Heart J. 2009 Sep; 158(3):356-63.
Score: 0.005
-
Predictors of carotid stent restenosis. Catheter Cardiovasc Interv. 2007 Apr 01; 69(5):673-82.
Score: 0.004
-
Power thrombectomy in acute ischemic coronary syndromes. Angiology. 2003 Jul-Aug; 54(4):457-68.
Score: 0.003
-
Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure: is there a difference in the elderly? Tex Heart Inst J. 2003; 30(3):176-9.
Score: 0.003
-
[Evaluation of post-intracoronary stent implant. Intravascular ultrasound versus quantitative angiography]. Arq Bras Cardiol. 1995 May; 64(5):439-46.
Score: 0.002
-
Anomalous coronary arteries: angiographic findings in 80 patients. Int J Cardiol. 1992 Feb; 34(2):129-38.
Score: 0.001
-
Young adult survivors of sudden cardiac arrest: analysis of invasive evaluation of 22 subjects. Am Heart J. 1989 Aug; 118(2):281-7.
Score: 0.001